Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Menarini Enters into an Exclusive Licensing Agreement with Daiichi Sankyo to Commercialise TARLIGE(R) in Singapore, Malaysia, and the Philippines
2021-08-23 09:00
Inclusion of Kintor as a Constituent Stock of HSCI
2021-08-23 08:44
Ocumension Therapeutics Announces 2021 Interim Results
2021-08-21 00:19
Roche and KeChow Reach a Cooperation Agreement
2021-08-20 23:00
CStone Pharmaceuticals Selected as a Constituent of HSCI
2021-08-20 20:24
Standigm Expands Global Footprints with New Office in Cambridge, UK
2021-08-20 15:30
Daewoong Pharmaceutical and Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics
2021-08-19 21:00
PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases
2021-08-19 20:00
I-Mab Announces Establishment of Environmental, Social and Governance Committee
2021-08-19 19:00
Zhaoke Ophthalmology's Phase III Clinical Trial of Cyclosporine A (CsA) Ophthalmic Gel for Dry Eye Disease Meets Primary Endpoint
2021-08-19 12:43
Senhwa's Silmitasertib Receives US FDA Fast Track Designation for the Treatment of Recurrent Sonic Hedgehog Driven Medulloblastoma
2021-08-19 10:57
MicroConstants to Join BioAgilytix Family
2021-08-19 02:30
MicroConstants to Join BioAgilytix Family
2021-08-19 02:30
Henlius reports half-year (H1) 2021 results, outlines remarkable growth in commercialization and needs-driven innovation
2021-08-18 21:35
Seegene Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
2021-08-18 18:00
Transcenta Held Investigator Meeting and Initiated Phase IIa Clinical Trial of Claudin18.2 Monoclonal Antibody TST001 with First Patient Dosed Successfully
2021-08-18 08:00
Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet
2021-08-18 08:00
PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021
2021-08-17 22:02
Holmusk signs agreements with UTHealth and The Harris Center
2021-08-17 21:00
I-Mab to Provide Business and Corporate Updates and Report Financial Results for the Six Months Ended June 30, 2021 on August 31, 2021
2021-08-17 20:00
1
228
229
230
231
232
413